George G, Vikman H, Gedeborg R, Franck Lissbrant I, Garmo H, Styrke J, et al. Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden. AO [Internet]. 2021 Apr. 3 [cited 2026 May 31];60(4):459-65. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/21465